• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Biohaven Pharmaceuticals











Oh yes, and doctors are so loyal to only speaking for one drug...lmfao! And gee, no drug class ever had a competitor come out a few months earlier but later got dominated by the late-comer...your sir/mam are clueless about this industry.
 




Total waste of time! These managers are passing on reps with experience...horrible


Don't blanket-state that all managers are passing on prior experience. Just like any other company and industry whether or not you get hired doesn't just come down...oh..ya but I have experience....I know several hungry reps with almost no pharma experience who will kick the crap out of tenured, lazy...Im experienced reps.
 




riiiiight!!!! in your dreams. their max is $115K in NE and some questionable characters in management....


Hey idiot..name a pharma company...or ANY company for that matter, that doesn't have some questionable characters in management. Many of the biggest and supposed best, companies in pharma that I have worked for are chock-full.
 












Watching. It’s what many do. And this company has crap written all over it. Docs aren’t buying in.. and neither are lots of the rest of industry ..Again. You can keep rationalizing your choice. Stupid is as stupid does . baaadddd deal.. see how it feels next summer when you can’t get access or scripts.

So..let me get this straight..you have been out surveying doctors to see if they are buying in..then you went and did an industry survey to see if "lots" of them are buying in? This post is so stupid I hardly know where to begin. First, docs have never even heard of Biohaven considering they are a brand new player. Second, what "industry" players are you referring to? Do some freaking reading..this company has been on Mad Money, and the first drug (of many they have in late-stage) itself is expected to do 1b in two years
 












Biohaven.. good luck. Last in.. tough market to get to with no relationships or access. You will have the pressure.

No relationships or access? Are you for some reason thinking they staffed this company with flunkies from Kinkos? I personally know 12-15 people in my region alone that have a minimum of 10 years experience, many with migraine and neurology experience that goes back over 20 including myself.
 




Good luck Biohaven. It better be good or you are out. Allergan has presence already and if you are the same it’s a no go. Late to the party .. tough to catch up. 5 reps quit in our area and have moved on.. writing on the wall

You are so full of crap. What, 5 reps quit while they were being paid over 100k to basically wait for launch? Ya, I doubt it. And dude, there are countless drugs that came to market 2nd 3rd..even later in crowded classes and did just fine. This is a huge market and there will be plenty of soup to feed everyone.
 




Customers favor the Ivy League Amgen country club pedigree and their first to market, superior drug. They won't sink to using a triptan with lipstick on it from a chop shop, penny stock wannabe company. There will be limited pen to pad and profitability will never be reached. The Wharton noodlers at Amg have run every model and the result is the same, infinite disaster.

Penny stock? Try NYSE flunkie. Superior drug? Not a single slice of research to demonstrate that either. And fyi..Ivy league Biohaven is linked up with Yale...so suck it biff.
 




























What are you talking about? 600 reps nationwide is a tiny sales force.

Hopefully you all asked the question in the interview process why they were hiring so many so quick. “Over saturate our targets with multiple voices quickly”...then cut when that window closes. Fine print is when the drug launch is naturally slow, which it will be in a crowded market. BH will be forced to choose between the two reps in the given territories. Who produces and who doesn’t? Cuts by end of 2021. Good luck to all!